| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |